United States - English - NLM (National Library of Medicine)

physicians total care, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - for the treatment of functional bowel/irritable bowel syndrome. - obstructive uropathy - obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions ) - reflux esophagitis reflux esophagitis - unstable cardiovascular status in acute hemorrhage - glaucoma - myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations - infants less than 6 months of age (see warnings and precautions: information for patients . ) - nursing mothers (see warnings and precautions: information for patients . ) abuse and/or dependence on dicyclomine for anticholinergic effects have been rarely reported.

United States - English - NLM (National Library of Medicine)

stat rx usa - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - for the treatment of functional bowel/irritable bowel syndrome. - obstructive uropathy - obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions ) - reflux esophagitis - unstable cardiovascular status in acute hemorrhage - glaucoma - myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of this formulation - infants less than 6 months of age (see warnings and precautions : information for patients .) - nursing mothers (see warnings and precautions : information for patients .)

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] , and in patients with: pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to women who took products containing dicyclomine hydrochloride at doses up to 40 mg/day during the first trimester of pregnancy. reproduction studies have been performed in rats and rabbits at doses of up to 33 times the maximum recommended human dose based on 160 mg/day (3 mg/kg) and have revealed no evidence of harm to the fetus due to dicyclomine.  because animal reproduction studies are not always predictive o

United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, llc dba vangard labs - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - dicyclomine hydrochloride capsules, usp are indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)], nursing mothers [see use in specific populations (8.3)] and in patients with: •     unstable cardiovascular status in acute hemorrhage •     myasthenia gravis [see warnings and precautions (5.4)] •     glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] •     obstructive uropathy [see warnings and precautions (5.8)] •     obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] •     severe ulcerative colitis [see warnings and precautions (5.7)] •     reflux esophagitis pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased risk of struc

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - dicyclomine hydrochloride tablets are indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific p opu l a ti on s (8.4) ] , nursing mothers [see use in specific populations (8.3)] and in patients with: •     unstable cardiovascular status in acute hemorrhage •     myasthenia gravis [see warnings and precautions (5.4)] •     glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] •     obstructive uropathy [see warnings and precautions (5.8)] •     obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] •     severe ulcerative colitis [see warnings and precautions (5.7)] •     reflux esophagitis p r e g n a n c y category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an incr

United States - English - NLM (National Library of Medicine)

h.j. harkins company, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] , and in patients with: - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [see warnings and precautions (5.4)] - glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] - obstructive uropathy [see warnings and precautions (5.8)] - obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] - severe ulcerative colitis [see warnings and precautions (5.7)] - reflux esophagitis pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to w

United States - English - NLM (National Library of Medicine)

blenheim pharmacal, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - for the treatment of functional bowel/irritable bowel syndrome. - obstructive uropathy - obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions ) - reflux esophagitis reflux esophagitis - unstable cardiovascular status in acute hemorrhage - glaucoma - myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations - infants less than 6 months of age (see warnings and precautions: information for patients . ) - nursing mothers (see warnings and precautions: information for patients . )

United States - English - NLM (National Library of Medicine)

stat rx usa llc - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - for the treatment of functional bowel/irritable bowel syndrome. 1. obstructive uropathy 2. obstructive disease of the gastrointestinal tract 3. severe ulcerative colitis (see  precautions) 4. reflux esophagitis 5. unstable cardiovascular status in acute hemorrhage 6. glaucoma 7. myasthenia gravis 8. evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations 9. infants less than 6 months of age (see  warnings and  precautions: information for patients.) 10. nursing mothers (see  warnings and  precautions: information for patients.)

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] and in patients with: adequate and well-controlled studies have not been conducted with dicyclomine in pregnant women at the recommended doses of 80 mg/day to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to women who took products containing dicyclomine hydrochloride at doses up to 40 mg/day during the first trimester of pregnancy. reproduction studies have been performed in rats and rabbits at doses up to 33 times the maximum recommended human dose based on 160 mg/day (3 mg/kg) and have revealed no evidence of harm to the fetus due to dicyclomine. because animal reproduction studies are not always predictive of human response, this drug shoul

United States - English - NLM (National Library of Medicine)

rebel distributors corp - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - for the treatment of functional bowel/irritable bowel syndrome. abuse of and/or dependence on dicyclomine for anticholinergic effects have been rarely reported.